SIRT5 and diabetes mellitus: Due to the potential role of SIRT5 as a pharmacological target in cancer, diabetes, cardiovascular diseases, obesity, neurodegenerative disorders, and inflammation, many studies have been undertaken to identify new molecules acting as SIRT5 activators or inhibitors.